Antimicrobial peptides
(AMPs) are seen as a promising replacement
to conventional antibiotics for the prevention of skin wound infections.
However, due to the short half-life of AMPs in biological environments,
such as blood, their use in clinical applications has been limited.
The covalent immobilization of AMPs onto suitable substrates is an
effective solution to create contact-killing surfaces with increased
long-term stability. In this work, an antimicrobial peptide, RRPRPRPRPWWWW-NH2
(RRP9W4N), was covalently attached to amphiphilic and ordered mesoporous
Pluronic F127 hydrogels made of cross-linked lyotropic liquid crystals
through 1-ethyl-3-(3-(dimethylamino)propyl) carbodiimide (EDC) and
N
-hydroxysuccinimide (NHS) chemistry. The AMP-hydrogels
showed high antibacterial activity against
Staphylococcus
epidermidis, Staphylococcus aureus
,
Pseudomonas aeruginosa
, methicillin-resistant
S. aureus
(MRSA), and multidrug-resistant
Escherichia coli
for up to 24 h. Furthermore,
the AMP-hydrogels did not present any toxicity to human fibroblasts.
The AMPs retained their antimicrobial activity up to 48 h in human
blood serum, which is a significant increase in stability compared
to when used in dissolved state. A pilot
in vivo
rat
model showed 10–100× less viable counts of
S.
aureus
on AMP-hydrogels compared with control hydrogels during
the first 3 days of infection. Studies performed on human whole blood
showed that blood coagulated more readily in the presence of AMP-hydrogels
as compared to hydrogels without AMPs, indicating potential hemostatic
activity. Overall, the results suggest that the combination of amphiphilic
hydrogels with covalently bonded AMPs has potential to be used as
antibacterial wound dressing material to reduce infections and promote
hemostatic activity as an alternative to antibiotics or other antimicrobial
agents, whose use should be restricted.